Transcription of CTN-0030 Protocol Book
{{id}} {{{paragraph}}}
Example: confidence
CTN-0030 Protocol Book
NIDA-CTN-0030A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic DependenceNATIONAL INSTITUTE ON DRUG ABUSECLINICAL TRIALS NETWORKP rotocol ( 2007)CONTACT INFORMATION FOR INVESTIGATORS/COLLABORATORST itleNameAffiliationLead Investigator for Protocol Implementation(LI)Roger Weiss, New England NodeLead Investigator for Protocol DevelopmentWalter Ling, NodeProject DirectorJennifer Sharpe Potter, , MPHN orthern New England NodeProject Co-DirectorAl Hasson, Pacific NodeProject ManagerKristi Prather, New England NodeMedical MonitorHilary Connery, , New England NodeSafety MonitorRobert Lindblad, Coordinating CenterBiostatisticiansEva Petkova, Island NodeJanet Levy, CCTNR egulatory SpecialistScott Provost, , New England NodeTraining DirectorMarc Copersino, New England NodeNIDA LiaisonsJack Blaine, CCTNP etra Jacobs, CCTNE xecutive CommitteeFranklin Ingram, Carolina Node Carmen Masson, NodeMichael Bogenschutz, NodeJeff Selzer, Island NodeNathaniel Katz, New England NodeMichele Straus.
NIDA-CTN-0030 A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: